Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States | Zendy

Jessie K. Edwards | Zendy; Stephen R. Cole | Zendy; Daniel Westreich | Zendy; Michael J. Mugavero | Zendy; Joseph J. Eron | Zendy; Richard D. Moore | Zendy; William C. Mathews | Zendy; Peter W. Hunt | Zendy; Carolyn Williams | Zendy

Open Access

Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States

Author(s) -

Jessie K. Edwards,

Stephen R. Cole,

Daniel Westreich,

Michael J. Mugavero,

Joseph J. Eron,

Richard D. Moore,

William C. Mathews,

Peter W. Hunt,

Carolyn Williams

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ463

Subject(s) - medicine , confidence interval , antiretroviral therapy , cohort , young adult , cohort study , viral load , immunology , human immunodeficiency virus (hiv)

The goal of targeted antiretroviral therapy initiation is to minimize disease progression among patients with human immunodeficiency virus while minimizing the therapeutic burden on these patients. We examine whether the effect of delaying therapy initiation from 500 cells/mm(3) to 350 or 200 cells/mm(3) is modified by age at entry into care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research